VC-backed DBV Technologies debuts IPO
French biopharmaceutical firm DBV Technologies rolled out its IPO after having priced its over 2.67 million shares at $21.64 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol "DBVT." Citigroup Global Markets, Leerink Partners, Trout Capital, Bryan, Garnier & Co. were the underwriters. DBV's backers include Apax Partners, InnoBio Fund, Lundbeckfond Ventures. Shire plc, ALTO Invest, Sofinnova Partners and ALK Abello.
22 October 2014•4 mins read
